AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.93
-0.15 (-2.47%)
Aug 7, 2026, 4:00 PM EDT - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $213.58 million as of August 10, 2026. Its market cap has increased by 558.39% in one year.
Market Cap
213.58M
Enterprise Value
128.29M
1-Year Change
558.39%
Ranking
Category
Stock Price
$5.93
ChartMarket Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $213.58M, a decrease of -24.02%. That is a compound annual growth rate of -6.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 213.58M | 583.70% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compugen | 228.29M |
| Galectin Therapeutics | 227.21M |
| Keros Therapeutics | 221.07M |
| Camp4 Therapeutics | 220.17M |
| Invivyd | 218.01M |
| Conexeu Sciences | 215.94M |
| Atrium Therapeutics | 211.08M |
| Greenwich LifeSciences | 210.78M |